Long-Term Management of Gout Nonpharmacologic and Pharmacologic Therapies

被引:16
|
作者
Chaichian, Yashaar [1 ]
Chohan, Saima [1 ]
Becker, Michael A. [1 ]
机构
[1] Univ Chicago, Rheumatol Sect, Chicago, IL 60637 USA
关键词
Gout; Hyperuricemia; Risk reduction; Urate-lowering therapy; Allopurinol; Febuxostat; Uricosuric agents; Pegloticase; URIC-ACID LEVEL; NUTRITION EXAMINATION SURVEY; URATE-LOWERING THERAPY; 3RD NATIONAL-HEALTH; SERUM URATE; RISK-FACTORS; ANTIHYPERURICEMIC THERAPY; INCIDENT GOUT; HYPERSENSITIVITY SYNDROME; CONVENTIONAL TREATMENT;
D O I
10.1016/j.rdc.2014.01.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gout is a common disorder with clinical signs and symptoms resulting from inflammatory responses to monosodium urate crystals deposited in tissues from extracellular fluids saturated for urate. Long-term management of gout focuses on nonpharmacologic and pharmacologic means to achieve and maintain serum urate levels in a subsaturating range. Despite a firm understanding of gout pathophysiology, means to achieve certain diagnosis, and a variety of effective therapies, treatment outcomes remain suboptimal. In this review, available nonpharmacologic and pharmacologic therapies for chronic gout are discussed and a framework is provided for successful achievement and maintenance of goal-range serum urate levels.
引用
收藏
页码:357 / +
页数:19
相关论文
共 50 条